ELV

Business Context and Reporting Period

This summary covers the Annual Report on Form 10-K for WellPoint, Inc. (now Elevance Health) for the fiscal year ended December 31, 2007. WellPoint is the largest health benefits company in the United States by commercial membership, serving 34.8 million medical members. The company operates as an independent licensee of the Blue Cross and Blue Shield Association (BCBSA) in 14 states and nationally as UniCare. Its operations are organized into three reportable segments: Consumer and Commercial Business (CCB), Specialty, Senior and State Sponsored Business (4SB), and Other (primarily Federal Government Solutions).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Operating revenue increased 7% to $60.1 billion, driven by premium rate increases in Local Group, growth in State Sponsored business (addition of five new states), and growth in Medicare Advantage products.
• Profitability: Net income rose 8% to $3.3 billion. Diluted EPS increased 15% to $5.56, aided by a reduction in share count due to repurchases.
• Membership: Total medical membership grew 2% to 34.8 million. Gains in National Accounts and State Sponsored business offset declines in Local Group and Individual segments.
• Expense Ratios: The benefit expense ratio increased 120 basis points to 82.4%, primarily due to higher medical cost trends in the 4SB segment. Conversely, the SG&A ratio improved by 120 basis points to 14.5% due to revenue growth and cost leverage.
• Debt: Long-term debt increased significantly to $9.0 billion, reflecting the issuance of approximately $2.0 billion in new debt during 2007.

Guidance, Outlook, and Risks

• Strategic Outlook: Management aims to achieve at least 15% growth in EPS through organic membership growth, strategic acquisitions, disciplined pricing, and cost optimization. The company announced a new organizational structure effective January 1, 2008, to better align with customer types (Commercial vs. Consumer).
• Capital Allocation: The company maintains an aggressive stock repurchase program. In 2007, it repurchased 76.9 million shares for $6.2 billion. Approximately $4.3 billion remained authorized for future repurchases at year-end.
• Key Risks:
  • Health Care Costs: Rising medical costs and inflation could outpace premium rate increases, compressing margins.
  • Regulatory Environment: Changes in state and federal regulations, particularly regarding Medicaid/Medicare reimbursement and universal coverage proposals (e.g., in California), pose significant risks.
  • BCBSA License: Termination of the Blue Cross and Blue Shield license agreements could result in a "Re-establishment Fee" of approximately $2.4 billion and loss of brand value.
  • Intangible Assets: Goodwill and intangibles represent 44% of total assets; impairment charges could materially impact earnings.

Investor Verification Checklist

• Medical Cost Trends: Verify the sustainability of the 82.4% benefit expense ratio and the impact of rising outpatient and pharmacy costs on future margins.
• State Sponsored Performance: Review the profitability of the State Sponsored segment, specifically the impact of the Ohio and Connecticut Medicaid programs which contributed to margin deterioration.
• Debt Service Capacity: Assess the ability to service the increased debt load ($9.0 billion) given the company's reliance on dividends from regulated subsidiaries.
• Regulatory Exposure: Monitor legislative developments in key states (California, New York) regarding universal coverage and rate regulation.
• Stock Repurchase Sustainability: Evaluate whether the $4.3 billion remaining repurchase authorization is sustainable given the increased debt levels and capital requirements.